Search PubMed⌕ Search

Biomedical subjects

T Nishimura

Publications and source records attributed to T Nishimura.

At least 1,063 records · Page 59Linked to original sources

Calcium-dependent potassium conductance in neurons of rabbit vesical pelvic ganglia.

Intracellular recordings were made from neurons of vesical pelvic (parasympathetic) ganglia (VPG) isolated from the rabbit urinary bladder. Spontaneous hyperpolarizations (SH), occurring at intervals of 30 s to 5 min, could be recorded from 53% of VPG neurons in Krebs solution. The action potential was associated with inward sodium and calcium currents and was followed by fast and slow afterhyperpolarizations (AHPs). The action potential also evoked an additional hyperpolarization which was identical to the SH. The SH and the AHPs were associated with a decrease in the input resistance and reversed their polarity close to the potassium equilibrium potential. Intracellular cesium ions blocked the AHPs and the SH. Superfusing the preparation with a calcium-free solution produced a depolarization associated with an increased input resistance. The outward rectification activated at the resting membrane potential was depressed in the calcium-free solution. The removal of extracellular calcium ions also depressed both the SH and the spike AHPs. Bath-application of caffeine (1-3 mM) increased the frequency of the appearance of the SH. Injection of EGTA into VPG neurons caused a depolarization due to a blockade of the outward rectification. EGTA also depressed the slow AHP and the SH. These results suggest that the neuronal membrane of the rabbit VPG is endowed with a calcium-dependent potassium conductance (gKCa). Apamin (0.3-5 nM) and (+)-tubocurarine (30-300 microM) blocked the slow AHP and the SH without affecting the fast AHP and the resting membrane potential. Tetraethylammonium (TEA, 0.3-5 mM) suppressed the fast AHP and the SH without affecting the outward rectification. TEA augmented the slow AHP. Barium ions (0.1-1 mM) depressed the AHPs, the SH and the outward rectification. These pharmacological properties imply that at least 3 kinds of gKCa systems underlie the generation of the outward rectification, the spike AHPs and the SH.

Action Potentials↗

The effect of dietary restriction on mouse T cell functions.

Forty percent dietary restriction on 9-weeks-old C3H/He mice caused decrease of the weight of central lymphoid organs in parallel with the reduction of body weight. However, the percentage of splenic T cells was dramatically increased in diet-restricted mouse spleen cells. Generally, normal mouse spleen cells contained about 30% of Thy 1.2+ T cells, but the restricted mouse spleen cells contained 80% Thy 1.2+ T cells. Ly 1+, L3T4+ T cells, but not Ly 2+ T cells, also increased in diet-restricted mouse compared with the unrestricted mice. In parallel with the dramatic changes of splenic T cells, spleen cells obtained from diet-restricted mice showed higher immunological responses against alloantigen and interleukin 2. It was also demonstrated than nylon-passed splenic T cells obtained from diet-restricted mice showed higher levels of T cell responses against r-IL-2 and alloantigen, indicating that dietary restriction modulates T cell functions themselves.

Animals↗

Norepinephrine inhibits calcium action potential through alpha 2-adrenoceptors in rabbit vesical parasympathetic neurons.

Intracellular and voltage-clamp recordings were made from neurons in rabbit vesical parasympathetic ganglia (VPG) maintained in vitro. Norepinephrine (NE, 10 nM-10 microM) reduced the Ca2+ component of the action potential and the afterhyperpolarization. Clonidine and UK14304, the selective alpha 2-adrenoceptor agonists, mimicked the inhibitory effects of NE on the action potential. NE and UK14304 blocked the Ca2+ spike elicited in the presence of tetrodotoxin and tetraethylammonium. UK14304 suppressed the inward Ca2+ current induced by depolarizing step command under the voltage-clamp condition. These inhibitory actions were antagonized by yohimbine and idazoxan but not by prazosin and propranolol. It is suggested that alpha 2-adrenoceptors mediate the inhibition of voltage-dependent Ca2+ entry during the action potential.

Action Potentials↗

Localization of the human JUN protooncogene to chromosome region 1p31-32.

The oncogene jun is the putative transforming gene of avian sarcoma virus 17; jun appears to be derived from a gene of the chicken genome and has homologues in several other vertebrate species. Recent genetic and immunological data indicate that jun codes for a protein that is closely related and probably identical to the transcription factor AP-1. We have isolated a genomic DNA clone encompassing the human cellular counterpart of the gene, JUN, and used this DNA to determine the chromosomal location of the gene. A panel of DNA preparations derived from rodent-human somatic cell hybrids with defined chromosome complements was first screened with the JUN probe. This Southern blot analysis indicated that JUN is situated on the short arm of chromosome 1. In situ hybridization then assigned JUN to chromosome region 1p31-32, a chromosomal region involved in both translocations and deletions of chromosomes seen in human malignancies.

Animals↗

Assessment of severity of cardiac rejection in heterotopic heart transplantation using indium-111 antimyosin and magnetic resonance imaging.

Seven canine donor hearts in which atrial septal defect and tricuspid regurgitation had previously been produced were heterotopically transplanted into the recipients' chest cavities. Indium-111 antimyosin myocardial imaging of the excised heart was performed using a scinticamera. Magnetic resonance imaging was also performed and the T2 relaxation time calculated. Subsequently, these data were correlated with pathological findings, which indicated the degree of rejection. Indium-111 antimyosin uptake was high in moderate and severe rejection, but the T2 relaxation time was prolonged even in mild rejection. Thus indium-111 antimyosin uptake was specific, and the T2 relaxation time was sensitive, for detecting the severity and extent of cardiac rejection. Although ex vivo experimental results have been reported, these new methods allow characterisation and accurate evaluation of myocardial tissue undergoing cardiac rejection.

Animals↗

Disappearance of inhibitor to factor IX in a patient with severe haemophilia B and immunological characterization of the inhibitor.

Disappearance of an inhibitor to factor IX in an 11-year-old boy with haemophilia B is described. He had been given a total of 14,200 units of a prothrombin complex concentrate (PCC) before an inhibitor to factor IX developed. He subsequently received four separate infusions of PCC and his inhibitor titre rose in response to the treatment for the following 4 years. No inhibitor is presently detected despite repeated administration of PCC. Immunological characterization of the inhibitor by inhibitor neutralization assays, modified crossed-immunoelectrophoresis and enzyme-linked immunosorbent assay demonstrated that it contained IgG2 and IgG4 heavy chains and kappa and lambda light chains. No large deletion of the factor IX gene in the patient was observed using cDNA (cVII).

Child↗

Correlation of anionic residue mobility at the filopodial plasma membranes with multilayer formation in transformed 3T3 cells.

Simian virus 40-transformed 3T3 (SV40-3T3) cells formed multilayers on a Falcon dish and had numerous filopodial projections, some of which intertwined with those of adjacent cells, in contrast to the few projections of their nontransformed counterparts. When these cells were incubated with polycationic ferritin (0.5 mg/ml), ferritin particles, representative of anionic sites, were spread widely on their surfaces at 4 degrees C, while they formed clusters at 37 degrees C, especially on filopodial surface areas opposing adjacent projections in SV40-3T3 cells. These findings demonstrate an increase in the mobility of molecules with anionic residues on filopodial plasma membranes in SV40-3T3 cells, thus suggesting a role for these projections in the formation of multilayered cell aggregates.

Animals↗

Influence of somatostatin and growth hormone-releasing factor on behavior. Clinical and therapeutic implications in neuropsychiatric disorders.

Administration of hypothalamic peptides has been reported to induce behavioral changes and to modify neurological functions such as locomotor activity and learning. Somatostatin (SS) and growth hormone-releasing factor (GRF) exert opposite effects on anterior pituitary secretion. Similarly, at the central nervous system (CNS) level, SS and GRF display antagonistic actions on behavioral parameters. The authors were able to confirm these effects in male Wistar rats by means of a computerized electronic maze measuring locomotor activity and learning. SS concentration is reduced in specific areas of the CNS in patients with late onset of senile dementia of the Alzheimer's type (SDAT). In early onset SDAT a GRF test elicits a growth hormone response much greater than that observed in normal controls of the same age or in patients with late onset SDAT. Thus, administration of GRF to patients with early onset SDAT has been followed by a significant improvement in locomotion, appetite, mental performance and social interaction. A possible therapeutic role of GRF in the management of patients with dementia remains to be explored.

Animals↗

Double-chambered right ventricle demonstrated by magnetic resonance imaging before cardiac catheterization--case report.

Double-chambered right ventricle is often misdiagnosed clinically and may be missed at cardiac catheterization. The authors encountered a fifty-six-year-old man who had double-chambered right ventricle, which was clearly demonstrated by magnetic resonance imaging (MRI) before cardiac catheterization. The right ventricle was divided into two chambers by hypertrophic muscular bands at the coronal planes. This finding was confirmed by selective angiography, and the pressure gradient in the right ventricle was 98 mmHg. Thus, MRI should be performed in the case of right ventricular obstruction to evaluate the site and extent of obstruction before cardiac catheterization.

Angiocardiography↗

Antagonistic effects of growth hormone-releasing factor and somatostatin on brain histamine.

Studies on the morphological distribution of histamine (HA)-secreting neurons and their hypothalamic projections suggest that HA may play a key role in regulating neuroendocrine functions, some of which have been recently elucidated. To investigate possible interactions between the somatotropinergic and histaminergic systems in the brain, the effects of GRF-44 [0.1-10 micrograms intracerebroventricular (icv)] and somatostatin (SS-14; 0.1-10 micrograms, icv) on HA in five different parts of the hypothalamo-hypophyseal system, and in the hippocampus and frontal cortex, were studied using a highly sensitive HPLC system for determination of HA. GRF-44 (1 microgram, icv) elicited significant (P less than 0.005) increases in the concentration of HA in the anterior hypothalamus, posterior hypothalamus, median eminence, adenohypophysis, neurohypophysis, frontal cortex, and, to a lesser extent, in the hippocampus, after a clear time-dependent pattern with maxima 15 min after injection. In contrast, SS-14 (1 microgram, icv) significantly (P less than 0.005) decreased the levels of HA in all areas studied, except in the neurohypophysis. The SS-induced HA levels reached minima 30 min after injection. The antagonistic effects of GRF-44 and SS-14 on the release of brain HA were dose dependent, showing an inverse linear correlation within the range 0.1-10 micrograms in the anterior hypothalamus (r = -0.59) and posterior hypothalamus (r = -0.75). Responses of HA to GRF-44 and SS-14 (range: 0.1-10 micrograms) also exhibited an inverse linear correlation in the median eminence (r = -0.90) and adenohypophysis (r = -0.58), while in the hippocampus and frontal cortex the antagonistic effects of GRF and SS displayed an inverse curvilinear correlation. SS-14 ED50 values ranged from 0.6 to 1.75 nmol with Emax of 0.65-6.10 nmol. GRF-44 ED50 values ranged from 0.02-0.3 nmol and the Emax values oscillated between 0.2 and 1.90 nmol in the regions studied. The greatest responses of HA to GRF-44 and SS-14 were obtained in the hypothalamo-hypophyseal system. Although brain HA is present in both the neuronal and the mast cell compartments, changes induced in the concentration of HA by centrally administered GRF-44 and SS-14 appear to occur mostly in the neuronal compartment. Therefore, it is likely that the somatotropinergic and histaminergic systems reciprocally interact at the central level to regulate still unknown neuroendocrine functions.

Animals↗

A heterotrophic synchronous culture of Chlorella.

Based on the observation that photoautotrophically grown Chlorella cells fail to complete cell division under anaerobic condition in the dark, we devised a heterotrophic synchronous culture (HSC) system for this green alga. The system consists, at a temperature of 21 degrees C, of a 32 +/- 1 h period under 3% CO2 in air and the successive 12 +/- 1 h period under 0.5% O2 +/- 99.5% N2 (the sum of the two periods is equal to 44 +/- 1 h), using a semi-balanced medium containing glucose in an inorganic salt solution. This procedure could be successively repeated several times and the division index was practically 100%, as it is for Chlorella in the photoautotrophic synchronous culture (PSC). We believe this is the first successful HSC achieved by the method of alternating atmospheric oxygen tension. Synthetic patterns for DNA, RNA and protein as well as chlorophyll during the cell cycle of Chlorella in HSC were similar to those observed in PSC, and the respiratory activity of actively growing cells in HSC was twice that of those in PSC. It is hoped that this system, under the regimen of high and low oxygen tension, can be utilized for other eukaryotic cells.

Cell Count↗

Magnetic resonance imaging in familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion and cardiac enzymes.

Gated magnetic resonance imaging (MRI) was performed in 6 patients with familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion, and 12 patients with ordinary hypertrophic cardiomyopathy. The patients with ordinary hypertrophic cardiomyopathy and abnormal thickening of the septal wall and normal left ventricular dimensions, while the patients with familial hypertrophic cardiomyopathy had focal wall thinning (usually involving the apical-septal wall) and dilated left ventricle in addition to hypertrophied heart. The quantitative measurement for cardiac dimensions using MRI was similar to that found on echocardiography in all cases. In addition, inhomogeneous signal intensities at left ventricular wall were observed in 3 cases of familial hypertrophic cardiomyopathy, which may suggest the existence of myocardial fibrosis. Gated MRI should be performed for early detection and follow-up of hypertrophic cardiomyopathy, since some patients will progress from hypertrophic cardiomyopathy to dilated cardiomyopathy.

Adult↗

[Effects of cadralazine on the respiration, circulation, kidney, autonomic nervous system, digestive system, blood and so on].

The general pharmacological effects of cadralazine and its major metabolite ISF 2405 were studied by comparing them with those of hydralazine. Cadralazine at 3.0 mg/kg, i.v., increased respiratory movement and heart rate and decreased blood pressure in cats. Cadralazine at 3.0 mg/kg, i.v., inhibited the hypertensive response induced by adrenaline, but showed little effect on the hypotensive response induced by acetylcholine in cats. Cadralazine and ISF 2405 at 10(-4) g/ml had negative chronotropic effects on isolated guinea-pig atria. The drug at 2.5 mg/kg, p.o., inhibited the passage of BaSO4 in the gastrointestinal tract in mice. The drug at 5.0 mg/kg, i.d. or more inhibited gastric secretion in rats. Cadralazine, except at higher doses, had little effect on spontaneous gastric motility and uterine spontaneous movement in rats. Cadralazine at 2.5 mg/kg, p.o., or more reduced or tended to reduce urine volume and urinary excretion of electrolytes. The drug showed little effect on coagulation and osmotic fragility in blood cell in rats nor on hemolysis and platelet aggregation in rabbits. ISF 2405, however, showed slight or moderate influence on hemolysis at concentrations as high as 0.01-1.0%. Cadralazine at 5.0 mg/kg, p.o. or more antagonized carrageenin-induced hind paw edema in rats. In conclusion, these effects of cadralazine were found to be qualitatively identical with those of hydralazine.

Animals↗

GHRH-induced GH response in patients with senile dementia of the Alzheimer type.

To clarify the functional state of the somatotropinergic system at the hypothalamo-hypophyseal level in senile dementia of the Alzheimer type, the GHRH test was performed in three groups of subjects: a) healthy elderly subjects; b) early onset senile dementia patients; and c) late onset senile dementia patients. Intravenous administration of GHRH(1-44)NH2 (100 micrograms) elicited a marked plasma GH response with a maximum peak (709.54 +/- 259.0 pmol/l; P less than 0.005) 60 min after injection in patients with early onset senile dementia, but no significant response was detected in the other two groups. Electroencephalographic recording showed that GHRH modifies brain bioelectrical activity, decreasing frequency (0.52 +/- 0.15 Hz) and increasing amplitude (8.25 +/- 4.5 microV) of the electroencephalogram basic rhythm. The evaluation of mental performance and behaviour with a battery of different tests for mental assessment revealed that GHRH induces transient clinical changes in psychomotor behaviour. According to these results, it seems likely that the somatostatin deficiency reported in senile dementia of the Alzheimer type may account for the enhanced GHRH-induced GH response observed in patients with early onset senile dementia. In consequence, the GHRH test might constitute a useful antemortem marker for senile dementia of the Alzheimer type if the present results can be replicated in early stages of the disease.

Aged↗